Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
2.
Eur Ann Otorhinolaryngol Head Neck Dis ; 136(5): 397-399, 2019 Oct.
Article in English | MEDLINE | ID: mdl-30902554

ABSTRACT

INTRODUCTION: Only two reports in English literature have described cement foreign bodies in the external auditory canal. CASE SUMMARY: We present the case of a 37 year-old man with cement foreign body in the right external auditory canal. Removal of the foreign body was difficult because of severe adhesion to the external auditory canal and tympanic membrane. We therefore used acidic Burow's solution to dissolve the alkaline cement deposition. Application of Burow's solution immediately caused the deposition to take on a paste-like consistency that was easily removed. DISCUSSION: Burow's solution seems useful for removing cement foreign bodies in the external auditory canal.


Subject(s)
Acetates/administration & dosage , Ear Canal , Foreign Bodies/therapy , Adult , Humans , Male , Suction
3.
Br J Radiol ; 87(1041): 20140240, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25029296

ABSTRACT

OBJECTIVE: A planning target volume (PTV) margin formula for hypofractionated intracranial stereotactic radiotherapy (SRT) has been proposed under cone beam CT (CBCT) image guidance with a six-degrees-of-freedom (6-DOF) robotic couch. METHODS: CBCT-based registration using a 6-DOF couch reportedly led to negligibly small systematic positioning errors, suggesting that each in-treatment positioning error during the treatment courses for the patients employing this combination was predominantly caused by a random gaussian process. Under this assumption, an anisotropic PTV margin for each axis was formulated based on a gaussian distribution model. 19 patients with intracranial lesions who underwent additional post-treatment CBCT were consecutively selected, to whom stereotactic hypofractionated radiotherapy was delivered by a linear accelerator equipped with a CBCT imager, a 6-DOF couch and a mouthpiece-assisted mask system. Time-averaged patient-positioning errors during treatment were estimated by comparing the post-treatment CBCT with the reference planning CT images. RESULTS: It was suggested that each histogram of the in-treatment positioning error in each axis would approach each single gaussian distribution with a mean of zero. The calculated PTV margins in the x, y and z directions were 0.97, 1.30 and 0.88 mm, respectively. CONCLUSION: The empirical isotropic PTV margin of 2 mm used in our facility for intracranial SRT was consistent with the margin calculated by the proposed gaussian model. ADVANCES IN KNOWLEDGE: We have proposed a PTV margin formula for hypofractionated intracranial SRT under CBCT image guidance with a 6-DOF robotic couch.


Subject(s)
Cone-Beam Computed Tomography , Radiosurgery/methods , Radiotherapy Planning, Computer-Assisted/methods , Robotic Surgical Procedures , Surgery, Computer-Assisted , Adult , Aged , Aged, 80 and over , Dose Fractionation, Radiation , Equipment Design , Female , Humans , Imaging, Three-Dimensional , Male , Masks , Middle Aged , Patient Positioning , Radiosurgery/instrumentation
4.
Ann Oncol ; 25(1): 100-6, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24356621

ABSTRACT

BACKGROUND: The aim of this study was to construct a novel prediction model for the pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) using immune-related gene expression data. PATIENTS AND METHODS: DNA microarray data were used to perform a gene expression analysis of tumor samples obtained before NAC from 117 primary breast cancer patients. The samples were randomly divided into the training (n = 58) and the internal validation (n = 59) sets that were used to construct the prediction model for pCR. The model was further validated using an external validation set consisting of 901 patients treated with NAC from six public datasets. RESULTS: The training set was used to construct an immune-related 23-gene signature for NAC (IRSN-23) that is capable of classifying the patients as either genomically predicted responders (Gp-R) or non-responders (Gp-NR). IRSN-23 was first validated using an internal validation set, and the results showed that the pCR rate for Gp-R was significantly higher than that obtained for Gp-NR (38 versus 0%, P = 1.04E-04). The model was then tested using an external validation set, and this analysis showed that the pCR rate for Gp-R was also significantly higher (40 versus 11%, P = 4.98E-23). IRSN-23 predicted pCR regardless of the intrinsic subtypes (PAM50) and chemotherapeutic regimens, and a multivariate analysis showed that IRSN-23 was the most important predictor of pCR (odds ratio = 4.6; 95% confidence interval = 2.7-7.7; P = 8.25E-09). CONCLUSION: The novel prediction model (IRSN-23) constructed with immune-related genes can predict pCR independently of the intrinsic subtypes and chemotherapeutic regimens.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/genetics , Transcriptome/immunology , Breast Neoplasms/drug therapy , Breast Neoplasms/immunology , Chemotherapy, Adjuvant , Cyclophosphamide/administration & dosage , Epirubicin/administration & dosage , Female , Fluorouracil/administration & dosage , Genes, MHC Class II/drug effects , Humans , Middle Aged , Models, Biological , Multivariate Analysis , Neoadjuvant Therapy , Paclitaxel/administration & dosage , Prognosis , Retrospective Studies , Treatment Outcome
5.
Ann Oncol ; 23(12): 3051-3057, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22767585

ABSTRACT

BACKGROUND: The aim of this study was to investigate the clinicopathological characteristics of GATA binding protein 3 (GATA3)-positive breast cancers as well as the association of GATA3 expression with response to chemotherapy. PATIENTS AND METHODS: Tumor specimens obtained before neoadjuvant chemotherapy [paclitaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide)] from breast cancer patients (n = 130) were subjected to immunohistochemical and mutational analysis of GATA3 and DNA microarray gene expression analysis for intrinsic subtyping. RESULTS: Seventy-four tumors (57%) were immunohistochemically positive for GATA3. GATA3-positive tumors were significantly more likely to be lobular cancer, estrogen receptor (ER)-positive, progesterone receptor (PgR)-positive, Ki67-negative, and luminal A tumors. Somatic mutations were found in only three tumors. Pathological complete response (pCR) was observed in 8 (11%) GATA3-positive tumors and in 22 (39%) GATA3-negative tumors. multivariate analysis showed that tumor size, human epidermal growth factor receptor 2 (her2), and gata3 were independent predictors of pcr. CONCLUSIONS: GATA3-positive breast cancers showed luminal differentiation characterized by high ER expression and were mostly classified as luminal-type tumors following intrinsic subtyping. Interestingly, GATA3 was an independent predictor of response to chemotherapy, suggesting that GATA3 might be clinically useful as a predictor of a poor response to chemotherapy.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms , GATA3 Transcription Factor/metabolism , Paclitaxel/therapeutic use , Adult , Aged , Base Sequence , Breast Neoplasms/classification , Breast Neoplasms/drug therapy , Breast Neoplasms/metabolism , Cyclophosphamide/therapeutic use , Epirubicin/therapeutic use , ErbB Receptors/metabolism , Female , Fluorouracil/therapeutic use , Hepatocyte Nuclear Factor 3-alpha/metabolism , Humans , Ki-67 Antigen/metabolism , Middle Aged , Mucin-1/metabolism , Neoadjuvant Therapy , Receptors, Estrogen/metabolism , Receptors, Progesterone/metabolism , Sequence Analysis, DNA , Treatment Outcome
6.
Cancer Lett ; 314(2): 206-12, 2012 Jan 28.
Article in English | MEDLINE | ID: mdl-22018777

ABSTRACT

Association of estrogen receptor (ER), progesterone receptor (PR), HER2, Ki67 and 70-gene classifier (70-GC) with a response to paclitaxel (PAC) (n=79) or docetaxel (DOC) (n=55) was investigated in the neoadjuvant setting for breast cancer patients. Sensitivity of breast tumors to PAC, but not to DOC, was found to be significantly associated with ER negativity (P=0.003), PR negativity (P=0.007), and Ki67 positivity (P=0.007). Breast tumors classified into the responders by 70-GC showed a significantly (P=0.005) higher reduction rate to PAC and interestingly a significantly (P=0.009) lower reduction rate to DOC than those classified into the non-responders by 70-GC, suggesting that 70-GC might be useful for the differentiation of PAC-sensitive and DOC-sensitive breast tumors.


Subject(s)
Antineoplastic Agents, Phytogenic/therapeutic use , Breast Neoplasms/drug therapy , Paclitaxel/therapeutic use , Taxoids/therapeutic use , Breast Neoplasms/classification , Breast Neoplasms/genetics , Breast Neoplasms/pathology , Docetaxel , Female , Gene Expression Profiling , Humans , Ki-67 Antigen/analysis , Receptor, ErbB-2/analysis , Receptors, Estrogen/analysis , Receptors, Progesterone/analysis
7.
Ann Nucl Med ; 15(1): 33-40, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11355779

ABSTRACT

UNLABELLED: The radioactivity in the organs adjacent to the heart causes interference with the quantitative assessment of myocardial uptake of tracer on scintigraphy. In order to investigate how much the functions of these organs affect myocardial uptake seen in imaging, we compared the myocardial uptake measured by means of a gamma camera with the actual activity in the excised organs. METHODS: Thirty-three rats were imaged at 5, 10, 15, 30, 45, 60, 90 and 120 min after the administration of 99mTc-tetrofosmin, and % injected dose per pixel (%ID/pixel) for each organ was assessed on planar images (PI measurement). Percent injected dose per gram of tissue (%ID/g) in the heart as well as lungs, liver, gastrointestines and blood was measured by means of a well scintillation counter (WC measurement). Comparison between PI and WC measurements was performed with % uptake, the PI-to-WC ratio and heart-to-organ ratios. RESULTS: Our WC measurement showed an increase in cardiac uptake until 30 min (1.67 +/- 0.31%) postinjection and subsequent gradual decrease, whereas PI measurement showed maximum activity of 1.81 +/- 0.52% at 15 min postinjection. There was a prominent difference between the two measurements, particularly at 10 min, with a PI/WC ratio of about 1.6 times. Our WC measurement showed maximum pulmonary uptake at 15 min (0.87 +/- 0.31%) and a gradual decrease over 15 min, whereas PI measurement showed maximum uptake at 10 min (1.14 +/- 0.38%). There was hardly any variation in activity observed later than at 10 min. Our WC measurement showed hardly any variance in hepatic activity from 5 min (0.77 +/- 0.19%) to 30 min (0.69 +/- 0.27%) with a subsequent gradual decrease. The percent uptake in PI measurement was generally greater than that in WC measurement, and high values were found at 10 min and 15 min with PI/WC ratios of about 3.3 times and 2.3 times, respectively. CONCLUSION: Percent uptakes in PI measurement were greater than those in WC measurement. The difference between the two measurements was prominent in the early phases. The cardiac uptake in PI measurement was significantly greater than that in WC measurement at 10 min. It was considered that this discrepancy between the two measurements was caused by the Compton scatter from the organs adjacent to the heart.


Subject(s)
Organophosphorus Compounds/pharmacokinetics , Organotechnetium Compounds/pharmacokinetics , Animals , Heart/diagnostic imaging , In Vitro Techniques , Liver/diagnostic imaging , Liver/metabolism , Lung/diagnostic imaging , Lung/metabolism , Male , Myocardium/metabolism , Radionuclide Imaging , Radiopharmaceuticals/pharmacokinetics , Rats , Rats, Inbred Strains , Tissue Distribution
8.
J Mol Biol ; 307(1): 259-70, 2001 Mar 16.
Article in English | MEDLINE | ID: mdl-11243818

ABSTRACT

Although many descriptions of adaptive molecular evolution of vertebrate hemoglobins (Hb) can be found in physiological text books, they are based mainly on changes of the primary structure and place more emphasis on conservation than alterations at the functional site. Sequence analysis alone, however, does not reveal much about the evolution of new functions in proteins. It was found recently that there are many functionally important structural differences between human and a ray (Dasyatis akajei) Hb even where sequence is conserved between the two. We have solved the structures of the deoxy and CO forms of a second cartilaginous fish (a shark, Mustelus griseus) Hb, and compared it with structures of human Hb, two bony fish Hbs and the ray Hb in order to understand more about how vertebrate Hbs have functionally evolved by the selection of random amino acid substitutions. The sequence identity of cartilaginous fish Hb and human Hb is a little less than 40 %, with many functionally important amino acid replacements. Wider substitutions than usually considered as neutral have been accepted in the course of molecular evolution of Hb. As with the ray Hb, the shark Hb shows functionally important structural differences from human Hb that involve amino acid substitutions and shifts of preserved amino acid residues induced by substitutions in other parts of the molecule. Most importantly, beta E11Val in deoxy human Hb, which overlaps the ligand binding site and is considered to play a key role in controlling the oxygen affinity, moves away about 1 A in both the shark and ray Hbs. Thus adaptive molecular evolution is feasible as a result of both functionally significant mutations and deviations of preserved amino acid residues induced by other amino acid substitutions.


Subject(s)
Hemoglobins/chemistry , Amino Acid Sequence , Animals , Binding Sites , Crystallography, X-Ray , Evolution, Molecular , Heme/chemistry , Hemoglobins/genetics , Hemoglobins/physiology , Humans , Models, Molecular , Molecular Sequence Data , Mutation , Organophosphates/chemistry , Oxygen/metabolism , Protein Conformation , Sequence Homology, Amino Acid , Sharks , Species Specificity
9.
J Nucl Med Technol ; 28(1): 29-35, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10763778

ABSTRACT

OBJECTIVE: The purpose of this work was to develop functional parameters to analyze regional cardiac function using ECG-gated 99mTc-tetrofosmin SPECT. Our goal was to develop a methodology that used slice thickness correction, the generation of a time-activity curve and a polar map. METHODS: Fourteen normal patients without evidence of coronary artery disease were studied. One hour after intravenous injection of 740-1110 MBq (20-30 mCi) 99mTc-tetrofosmin, ECG-gated SPECT data were acquired by dividing a cardiac cycle into 12 frames. The SPECT data were reconstructed from 11 of 12 frames into 3 views. The reconstruction of these images was repeated after performing slice thickness correction. Excluding the effect of different apex-to-base lengths at any frame during a cardiac cycle, 10 short-axis images with the same slice thickness were obtained. Each short-axis image was divided by 40 radii into 40 segments. The time-activity curve was generated from the total counts included in each segment plus both neighboring segments. Subsequently the curve fitting was performed using the second Fourier function. RESULTS: From fitted curves and their differentials, we calculated end-systolic count, end-diastolic count, percent count increase, uptake, peak contraction rate, peak distention rate and contraction time. CONCLUSION: The functional polar maps visually demonstrated regional myocardial function. This method is expected to be helpful for assessing regional cardiac function using 99mTc-tetrofosmin.


Subject(s)
Heart/diagnostic imaging , Organophosphorus Compounds , Organotechnetium Compounds , Tomography, Emission-Computed, Single-Photon , Adult , Electrocardiography , Female , Humans , Image Processing, Computer-Assisted , Male , Radiopharmaceuticals , Software , Tomography, Emission-Computed, Single-Photon/methods
10.
Radiat Med ; 17(4): 311-5, 1999.
Article in English | MEDLINE | ID: mdl-10510905

ABSTRACT

PURPOSE: We analyzed the efficacy of initial local response of MBT by imaging obtained within two months after treatment, to determine if there are factors that may be important for the initial local response of the disease. If an earlier local tumor response can be expected from SRS, patients with a poor prognosis should be treated with this modality. METHODS: Thirty-six patients with 59 lesions were treated by linac radiosurgery. The primary tumor, peripheral dose, tumor volume, and CT enhancement pattern of the tumor before treatment (homogeneous or ring-enhancing) were chosen as factors related to local tumor response and were used in the statistical analysis. RESULTS: 1) The initial local response of radiation-resistant tumors to conventional EBRT was worse than that of other tumors. The initial local responses of MBT from breast carcinoma, colon carcinoma, and pulmonary carcinoma were good. 2) Excluding radioresistant tumors, the cases irradiated at 25 Gy or more tended to show good local control. 3) No statistically significant differences were found between local response and factors such as the enhancement pattern and tumor volume in the analysis of MBT.


Subject(s)
Brain Neoplasms/diagnostic imaging , Brain Neoplasms/surgery , Carcinoma/diagnostic imaging , Carcinoma/surgery , Radiosurgery/methods , Tomography, X-Ray Computed , Brain Neoplasms/secondary , Breast Neoplasms/pathology , Carcinoma/secondary , Colonic Neoplasms/pathology , Female , Follow-Up Studies , Humans , Kidney Neoplasms/pathology , Lung Neoplasms/pathology , Neoplasm Recurrence, Local , Treatment Outcome
11.
Nihon Igaku Hoshasen Gakkai Zasshi ; 59(4): 137-42, 1999 Mar.
Article in Japanese | MEDLINE | ID: mdl-10349312

ABSTRACT

The purpose of this study was to determine whether it is possible to predict the efficacy of therapeutic response to linac-based stereotactic radiosurgery for AVMs on the basis of the stagnation rate in the nidus, which was defined as follows: [(pooling time of contrast material in the nidus of AVM)/ (intracranial circulation time)] x 100. Cerebral angiograms of twenty-five AVMs were retrospectively evaluated, and the stagnation rates in the nidus were calculated before and one year after stereotactic radiosurgery. Reduction rate was also calculated by using angiography, and we statistically evaluated the relationship between the stagnation rates in the nidus and the reduction rates. The stagnation rates in the nidus prior to linac-based stereotactic radiosurgery were positively correlated with the reduction ratios of AVMs after stereotactic radiosurgery (r = 0.406, p = 0.0432). Our study suggested that a higher stagnation rate in the nidus of the AVM might be obliterated faster after linac-based stereotactic radiosurgery. Thus, calculation of the stagnation rate in the nidus before stereotactic radiosurgery is useful in predicting the efficacy of therapeutic response to linac-based stereotactic radiosurgery for AVMs.


Subject(s)
Cerebral Angiography , Intracranial Arteriovenous Malformations/surgery , Radiosurgery , Adolescent , Adult , Aged , Female , Humans , Intracranial Arteriovenous Malformations/diagnostic imaging , Male , Middle Aged , Retrospective Studies , Treatment Outcome
12.
Am J Gastroenterol ; 94(5): 1402-4, 1999 May.
Article in English | MEDLINE | ID: mdl-10235227

ABSTRACT

We report a 73-yr-old man with primary advanced gastric small cell carcinoma, pure type. A large, Borrman type I tumor was located from the cardia to the entire gastric fundus and upper body. Atypical cells showed a round nucleus, small nucleolus, dense to granular chromatin, and scant cytoplasm. The histological findings indicates an advanced stage and exposure to the gastric serosa. Mitotic figures were observed. There was a proliferation of a sheet-like, solid pattern, but no rosette-like, sqamoid, or glandular patterns. The neoplastic cells were positive for Leu-7 (CD57) and 123C3 (CD56, neural cell adhesion molecule, NCAM) on the surface membrane. We diagnosed this case as primary advanced gastric small cell carcinoma, pure type, and report that Leu-7 and 123C3 monoclonal antibodies are useful markers for gastric small cell carcinoma. The 32 previously reported cases of gastric small cell carcinoma are also reviewed.


Subject(s)
Carcinoma, Small Cell/pathology , Stomach Neoplasms/pathology , Aged , Carcinoma, Small Cell/chemistry , Carcinoma, Small Cell/diagnosis , Humans , Male , Stomach Neoplasms/chemistry , Stomach Neoplasms/diagnosis
13.
Clin Neuropathol ; 18(2): 80-3, 1999.
Article in English | MEDLINE | ID: mdl-10192702

ABSTRACT

Primary melanocytoma arising from the leptomeninges of the spinal cord is very rare. A surgical specimen of a thoracic meningeal tumor was resected from a 75-year-old woman complaining of gait disturbance was investigated. Magnetic resonance imaging and myelography showed a dumb-bell-type tumor in the subdural space at the 1st to 2nd thoracic vertebrae. The tumor was subtotally resected because of adhesion to the lamina and thoracic medulla. The localized, gelatinous black tumor showed a well-defined margin without dissemination or infiltration. The tumor had a thin capsule and was composed of solid proliferation of neoplastic melanocytes. Neither whorl formation nor foci of palisaded nuclei were observed. The neoplastic cells were of two major types: an epithelioid- or polygonal-shaped type and a spindle-shaped type, and had a large nucleus, a prominent nucleolus, coarse chromatin, and melanin-pigments in their cytoplasm. Only a few mitotic figures were observed. They were positive for HMB-45 and S-100 protein. This case was considered to be primary melanocytoma arising from the thoracic leptomeninges.


Subject(s)
Melanoma/pathology , Meningeal Neoplasms/pathology , Aged , Female , Humans , Spinal Cord Neoplasms/pathology
14.
Virchows Arch ; 432(5): 473-6, 1998 May.
Article in English | MEDLINE | ID: mdl-9645449

ABSTRACT

We report on a 61-year-old woman with coexisting early stage primary gastric plasmacytoma and sarcoidosis with hypercalcaemia. Laboratory data on admission showed hypercalcaemia, with 12.8 mg/dl, parathyroid hormone-related peptide (PTHrP) 1.2 pmol/l, C-PTHrP 69.5 pmol/l, and 1,25-dihydroxyvitamin D3 46.7 pg/ml. Neoplastic plasma cells proliferated in the propria mucosa of the stomach, showed a monoclonal immunoglobulin of cytoplasmic IgA (lambda light chain) and were positive for leucocyte common antigen and epithelial membrane antigen on paraffin section prepared from a stomach biopsy specimen. Russel bodies were present, as were crystals. Abundant sarcoid granulomas were observed in many of the regional lymph nodes around the stomach and in the dermis of a skin nodule. The patient underwent subtotal gastrectomy with administration of antimyeloma chemotherapy. We suggest that the hypercalcaemia in this patient was due to PTHrP production by neoplastic plasma cells.


Subject(s)
Hypercalcemia/complications , Plasmacytoma/complications , Sarcoidosis/complications , Stomach Neoplasms/complications , Cholecalciferol/blood , Female , Humans , Hypercalcemia/blood , Hypercalcemia/pathology , Immunohistochemistry , Middle Aged , Neoplasm Proteins/metabolism , Parathyroid Hormone-Related Protein , Plasmacytoma/blood , Plasmacytoma/pathology , Proteins/metabolism , Sarcoidosis/blood , Sarcoidosis/pathology , Stomach Neoplasms/blood , Stomach Neoplasms/pathology
15.
Nihon Igaku Hoshasen Gakkai Zasshi ; 57(8): 526-7, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9267144

ABSTRACT

Etiology of esophageal intramural pseudodiverticulosis is still unknown but several accompanying diseases have been reported, for example, reflux esophagitis, esophageal cancer, diabetes mellitus and so on. We have experienced a case of esophageal intramural pseudodiverticulosis with cancer improved by radiation therapy. In this case, there were esophageal cancer in the cervical esophagus, with intramural spreading in whole esophagus. This case was delivered irradiation to the entire esophagus by target rotation method. After irradiation, intramural pseudodiverticula, intramural spreading and primary site of esophageal cancer were improved. This is an interest case report that esophageal intramural pseudodiverticula with cancer was disappeared by radiation therapy.


Subject(s)
Carcinoma, Squamous Cell/radiotherapy , Diverticulum, Esophageal/radiotherapy , Esophageal Neoplasms/radiotherapy , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Squamous Cell/complications , Cisplatin/administration & dosage , Combined Modality Therapy , Diverticulum, Esophageal/complications , Esophageal Neoplasms/complications , Female , Fluorouracil/administration & dosage , Humans , Radiotherapy/methods , Radiotherapy Dosage
16.
Planta Med ; 63(3): 224-7, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9225603

ABSTRACT

The antinociceptive effects 134 extracts prepared from 45 species of mushrooms were examined by the acetic acid-induced writhing method. From the CH2Cl2 extract of Ganoderma lucidum among the active extracts, ganoderic acids A, B, G and H and compound C6 were isolated as the antinociceptive components.


Subject(s)
Analgesics/pharmacology , Basidiomycota , Heptanoic Acids/pharmacology , Lanosterol/analogs & derivatives , Plant Extracts/pharmacology , Acetic Acid , Animals , Aspirin/pharmacology , Japan , Lanosterol/pharmacology , Male , Mice , Mice, Inbred Strains , Pain/chemically induced , Pain/drug therapy , Species Specificity
17.
Pathol Res Pract ; 193(3): 219-22; discussion 223-4, 1997.
Article in English | MEDLINE | ID: mdl-9198107

ABSTRACT

A 49 year-old female had been suffering from primary myelofibrosis since February 1987 without receiving any treatment. In 1994, a breast mass was detected. Breast tumor biopsy revealed tubular carcinoma with intraductal components and multinucleated giant cells in the loose and myxoid stroma. The giant cells were thought to be megakaryocytes because both Factor VIII and platelet glycoprotein GP IIIa were detected in their cytoplasm. While additional mastectomy specimens and the axillary lymph nodes also revealed prominent myeloid metaplasia, there was no proliferation of the cancer cells. Granulocytic series stained for chloroacetate esterase and very few erythrocytic series were observed. This is the first case in which breast carcinoma and myeloid metaplasia coexisted in the same breast tumor.


Subject(s)
Adenocarcinoma/complications , Breast Neoplasms/complications , Primary Myelofibrosis/complications , Adenocarcinoma/pathology , Breast Neoplasms/pathology , Female , Humans , Middle Aged , Primary Myelofibrosis/pathology
18.
Radiat Med ; 14(4): 215-9, 1996.
Article in English | MEDLINE | ID: mdl-8916267

ABSTRACT

Since the introduction of linac radiosurgery in October 1994, we have treated 27 patients with 36 lesions. We treated nine AVM, 12 metastatic brain tumors, two malignant lymphomas, one anaplastic astrocytoma, two meningiomas, and one brain tumor of unknown pathology. In the follow-up examinations at least five months after treatment, the local control rate was 83% for the metastatic tumors, and two malignant lymphomas disappeared completely. In addition, satisfactory results have been obtained with AVM and other brain tumors without any side effects. In comparison with gamma-knife radiosurgery, linac radiosurgery has some disadvantages such as longer treatment time and cumbersome accuracy control, but if accuracy control is performed periodically, accuracies of 1 mm or less can be obtained. There is some strengths of linac radiosurgery as follow. 1) The acquisition cost is relatively low. 2) Dose distribution are equivalent to gamma-knife. 3) There is no field size limitation. 4) There is great flexibility in beam delivery and linac systems. Radiosurgery using linear accelerators seems to become widely accepted in the future.


Subject(s)
Brain Neoplasms/surgery , Intracranial Arteriovenous Malformations/surgery , Particle Accelerators , Radiosurgery/methods , Stereotaxic Techniques , Brain/pathology , Brain Neoplasms/diagnosis , Gadolinium DTPA , Humans , Intracranial Arteriovenous Malformations/diagnosis , Magnetic Resonance Imaging , Organometallic Compounds , Pentetic Acid/analogs & derivatives , Quality Control , Radiosurgery/standards
19.
Biosci Biotechnol Biochem ; 59(7): 1386-8, 1995 Jul.
Article in English | MEDLINE | ID: mdl-7670206

ABSTRACT

A gene encoding a homolog of the chymotrypsin-like serine protease (SAM-P20), which was isolated as the target enzyme of a protease inhibitor (SSI), was cloned from Streptomyces lividans 66. This gene contained an open reading frame of 1065 nucleotides encoding 354 amino acid residues with a putative prepro portion of 157 amino acid residues. The deduced amino acid sequence of the cloned gene had significant homology to those of members of Streptomyces extracellular chymotrypsin-like protease family. By Southern blot analysis, it was suggested that protease genes of this type are found at a high frequency in Streptomyces. In this sense, we propose to categorize this protease as a member of the 'SAL' series (SAM-P20-like proteases).


Subject(s)
Serine Endopeptidases/biosynthesis , Serine Endopeptidases/genetics , Streptomyces/enzymology , Streptomyces/genetics , Amino Acid Sequence , Base Sequence , Blotting, Southern , Cloning, Molecular , Molecular Sequence Data , Open Reading Frames
20.
Radiat Med ; 10(6): 246-9, 1992.
Article in English | MEDLINE | ID: mdl-1337619

ABSTRACT

Transarterial embolization given for hepatoma in a patient with Budd-Chiari syndrome resulted in hepatic infarction and inferior vena cava thrombosis. Transarterial membranotomy and repeated infusion of thrombolytic agents and anticoagulants directly in the thrombus brought about improvement of the circulation surrounding the liver and IVC, and recovery from hepatic failure.


Subject(s)
Budd-Chiari Syndrome/therapy , Embolization, Therapeutic/adverse effects , Heparin/administration & dosage , Thrombolytic Therapy , Thrombosis/drug therapy , Thrombosis/etiology , Budd-Chiari Syndrome/diagnostic imaging , Budd-Chiari Syndrome/etiology , Carcinoma, Hepatocellular/complications , Humans , Liver Neoplasms/complications , Male , Middle Aged , Radiography, Interventional , Thrombosis/diagnostic imaging , Urokinase-Type Plasminogen Activator/therapeutic use , Vena Cava, Inferior/diagnostic imaging
SELECTION OF CITATIONS
SEARCH DETAIL